JP2005312464A - Method for producing glycoside and transglucosylation product - Google Patents

Method for producing glycoside and transglucosylation product Download PDF

Info

Publication number
JP2005312464A
JP2005312464A JP2005213937A JP2005213937A JP2005312464A JP 2005312464 A JP2005312464 A JP 2005312464A JP 2005213937 A JP2005213937 A JP 2005213937A JP 2005213937 A JP2005213937 A JP 2005213937A JP 2005312464 A JP2005312464 A JP 2005312464A
Authority
JP
Japan
Prior art keywords
cgtase
producing
glycoside
enzyme
receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2005213937A
Other languages
Japanese (ja)
Inventor
Shigeji Mori
茂治 森
Masataka Goto
真孝 後藤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amano Enzyme Inc
Original Assignee
Amano Enzyme Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amano Enzyme Inc filed Critical Amano Enzyme Inc
Priority to JP2005213937A priority Critical patent/JP2005312464A/en
Publication of JP2005312464A publication Critical patent/JP2005312464A/en
Pending legal-status Critical Current

Links

Images

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To provide a method for producing a glycoside and a transglucosylation product by using γ-cyclodextrin glucanotransferase (γ-CGTase). <P>SOLUTION: The method for producing the glycoside and the transglucosylation product comprises treating a phenolic hydroxyl group-containing compound or a saccharide as a receptor and a proper sugar donor with γ-CGTase having wide receptor specificity and capable of acting in a wide pH region. For example, γ-CGTase produced by a Brevibacterium microorganism is used. <P>COPYRIGHT: (C)2006,JPO&NCIPI

Description

本発明は、γ−サイクロデキストリン・グルカノトランスフェラーゼ(以下、γ-CGTaseという)を用いた配糖体及び糖転移生成物の製造法に関する。より詳細には各種のフェノール性水酸基を有する化合物或いは糖類と、糖供与体にブレビバクテリウム(Brevibacterium)属の生産するγ-CGTaseを作用させることによる各種配糖体又は糖転移生成物の製造法に関する。   The present invention relates to a method for producing a glycoside and a glycosyl transfer product using γ-cyclodextrin glucanotransferase (hereinafter referred to as γ-CGTase). More specifically, a method for producing various glycosides or glycosyl transfer products by causing a compound or saccharide having various phenolic hydroxyl groups and γ-CGTase produced by Brevibacterium to act on a sugar donor. About.

従来より各種の配糖体は食品素材、食品添加物、医薬品等として注目されている。即ち、各種の配糖体は天然に少量づつではあるが広く存在し、また優れた生理活性を有するにも拘らず低毒性であること等に特徴がある。   Conventionally, various glycosides have attracted attention as food materials, food additives, pharmaceuticals, and the like. That is, various glycosides are naturally present in small quantities, but are widely present, and are characterized by low toxicity despite having excellent physiological activity.

例えば、アルブチンは、抗酸化作用、抗アレルギー作用、メラニン色素抑制作用等があることが知られ、安全性の高い皮膚外用剤として知られ、また、香のバランスを良好で保持する作用を有することから化粧料の保香ベースの成分として利用できる。また、カテコール、レゾルシノールの配糖体は、皮膚色素沈着症等の予防及び治療、頭皮のフケの発生防止効果が知られている。   For example, arbutin is known to have an antioxidant effect, antiallergic effect, melanin inhibitory action, etc., and is known as a highly safe topical skin preparation, and also has an action of maintaining a good balance of incense. It can be used as a fragrance-based ingredient in cosmetics. In addition, glycosides of catechol and resorcinol are known to prevent and treat skin pigmentation and the like and to prevent the occurrence of dandruff on the scalp.

このように、フェノール化合物は、種々の生理活性を有し、有用な物質であり、これを配糖体化することにより、その生理活性を損なうことなく、副作用や、水に対する溶解性等の問題点を改善することが期待されている。   As described above, phenolic compounds have various physiological activities and are useful substances. By converting them into glycosides, problems such as side effects and solubility in water can be obtained without impairing their physiological activities. It is expected to improve the point.

また、ポリフェノール配糖体は、従来から、甘味料、鎮痛剤、下剤、抗マラリヤ剤および強壮剤等として利用されるだけでなく、優れた美白効果を発揮する化粧品の配合成分としても利用できる有用な化合物であり、酵素の分子間転移反応を利用して各種の配糖体を製造する方法は従来より種々報告されている。   In addition, polyphenol glycosides are conventionally used not only as sweeteners, analgesics, laxatives, antimalarial agents, tonics, etc., but also useful as cosmetic ingredients that exhibit excellent whitening effects. Various methods for producing various glycosides using an intermolecular transfer reaction of an enzyme have been reported.

例えば、糖及びアルコール性水酸基に糖転移を行なうアミラーゼに関する研究[アミラーゼシンポジウム、10巻、81〜89頁(1975)]、フェノール化合物に糖供与体の存在下、シュークロースホスホリラーゼを作用させることによるフェノール配糖体の製造法(特開平6-153976)、コウジ酸に糖供与体の存在下、シュークロースホスホリラーゼを作用させることによるコウジ酸配糖体の製造法(特開平6-056872)、ハイドロキシフラノンに糖供与体の存在下、シュークロースホスホリラーゼを作用させることによるフラノン配糖体の製造法(特開平6-135987)、エラグ酸にサイクロデキストリン等の糖供与体の存在下、サイクロデキストリン合成酵素を作用させることによるエラグ酸配糖体の製造法(特開平5-331183)、キシランおよびメチロール置換フェノール誘導体の混合物に、キシラナーゼを作用させることによるキシロオリゴシル配糖体の製造法(特開平6-087880)、キシランおよびアリールアルカノールの混合物にキシラナーゼを作用させて配糖体を製造する方法(特開平6-172403)、セルラーゼの存在下において、糖基質とポリフェノール受容体を反応させることによるβ型ポリフェノール配糖体の製造法(特開平6-284897)、サイクロデキストリン合成能とマルトース分解能を有さない新規な酵素を用いるポリフェノール配糖体の製造法(特開平6-284896)等種々報告されている。   For example, studies on amylases that transfer sugars to sugars and alcoholic hydroxyl groups [Amylase Symposium, Vol. 10, pp. 81-89 (1975)], phenols by allowing sucrose phosphorylase to act on phenolic compounds in the presence of sugar donors A method for producing glycosides (Japanese Patent Laid-Open No. 6-153976), a method for producing kojic acid glycosides by reacting kojic acid with sucrose phosphorylase in the presence of a sugar donor (Japanese Patent Laid-Open No. 6-056872), hydroxyfuranone A method for producing a furanone glycoside by reacting sucrose phosphorylase in the presence of a sugar donor (JP-A-6-135987), and a cyclodextrin synthase in the presence of a sugar donor such as cyclodextrin in ellagic acid For producing ellagic acid glycosides by reacting them (JP-A-5-331183), xylan and methylol placement A method for producing a xylo-oligosyl glycoside by allowing xylanase to act on a mixture of phenol derivatives (Japanese Patent Laid-Open No. 6-087880), and a method for producing a glycoside by allowing xylanase to act on a mixture of xylan and arylalkanol (Japanese Patent Laid-open No. 6-172403), a method for producing β-type polyphenol glycosides by reacting a sugar substrate with a polyphenol acceptor in the presence of cellulase (JP-A-6-284897), having no cyclodextrin synthesis ability and maltose resolution Various methods such as a method for producing a polyphenol glycoside using a novel enzyme (JP-A-6-284896) have been reported.

更に、糖に各種の酵素を用いた糖転移反応についても多く報告されている。例えば、β−ガラクトシダーゼを用いる方法(特公昭63-18457、特公昭63-65301、特開平1-137991、特開平2-84191、特公平2-57902、特開平6-38785等)、β−D−マンナナーゼを用いる方法(特開平5-153992)、β1,6-N-アセチルグルコサミニルトランスフェラーゼを用いる方法(特開平6-197756)、バチルス・セレウス由来の酵素を用いる方法(特開平6-298791)、バチルス・ステアロサーモフィラス由来のCGTaseを用いる方法(特公昭53-27791)などがある。
特開昭61-274680号公報 特開昭62-25976号公報 特開平6-113842号公報 特開平6-113843号公報 New trend in cyclodextrins and derivatives 25頁(1991年)サンテ(Sante)社(フランス、パリ)出版
In addition, many transglycosylation reactions using various enzymes for sugar have been reported. For example, a method using β-galactosidase (JP-B-63-18457, JP-B-63-65301, JP-A-1-37991, JP-A-2-84191, JP-B-2-57902, JP-A-6-38785, etc.), β-D -A method using mannanase (Japanese Patent Laid-Open No. 5-155392), a method using β1,6-N-acetylglucosaminyltransferase (Japanese Patent Laid-Open No. 6-197756), a method using an enzyme derived from Bacillus cereus (Japanese Patent Laid-Open No. 6-298791) ), A method using CGTase derived from Bacillus stearothermophilus (Japanese Patent Publication No. 53-27791).
JP 61-274680 JP 62-25976 A Japanese Patent Laid-Open No. 6-11842 Japanese Patent Laid-Open No. 6-113843 New trend in cyclodextrins and derivatives, 25 pages (1991), published by Sante (Paris, France)

しかしながら、種々の配糖体や糖転移生成物を得るこれらの方法においては、使用する酵素の受容体特異性が問題であり、従来と比べより広い受容体特異性を持ち、更に対象とする化合物に応じて、広いpH範囲で作用できる方法の開発が望まれていた。   However, in these methods of obtaining various glycosides and glycosyl transfer products, the receptor specificity of the enzyme used is a problem. Accordingly, it has been desired to develop a method capable of operating in a wide pH range.

そこで本発明者等はこのような問題点を解決するため、種々検討を重ねた結果、γ-CGTaseを用いて各種配糖体を製造することによって、より広い受容体特異性が発揮されることを見い出し本発明を完成した。   Therefore, the present inventors have conducted various studies to solve such problems, and as a result, a wider variety of receptor specificities can be exhibited by producing various glycosides using γ-CGTase. And the present invention was completed.

即ち、本発明はフェノール性水酸基を有する化合物或いは糖類と、糖供与体にγ-CGTaseを作用させることを特徴とする配糖体或いは糖転移生成物の製造法に関する。   That is, the present invention relates to a method for producing a glycoside or a glycosyl transfer product characterized in that a compound or saccharide having a phenolic hydroxyl group and γ-CGTase are allowed to act on a sugar donor.

広い受容体特異性を持つγ-CGTaseを使用することにより、フェノール性水酸基を有する化合物の配糖体を効率よく製造することができ、更に糖転移生成物も製造することができる。本発明の方法は広いpH領域、即ち、中性〜アルカリ性においても実施することができる。   By using γ-CGTase having a wide receptor specificity, a glycoside of a compound having a phenolic hydroxyl group can be efficiently produced, and a glycosyl transfer product can also be produced. The process of the present invention can be carried out in a wide pH range, that is, neutral to alkaline.

以下、本発明を詳細に説明する。
本発明により得られる配糖体の製造法は次の通りである。フェノール、1,3−ジヒドロキシベンゼン、3−ヒドロキシベンジルアルコール、(+)カテキン又はコウジ酸等のフェノール性水酸基を有する化合物0.1〜30%、好ましくは0.5〜5%と、マルトオリゴ糖、アミロース、アミロペクチン又は各種スターチ等の糖供与体0.1〜30%、好ましくは0.5〜20%とを含む溶液に、γ-CGTaseを添加し、20〜60℃、好ましくは30〜50℃で1〜48時間、好ましくは10〜24時間作用させ、反応液を得る。当該反応のpHは使用する酵素の至適pHが良いが反応物の溶解性などを考慮して定めることができる。例えば、3〜11で、好ましくは5〜9である。反応液を各種溶媒による分配及び各種クロマトグラフィーによる精製することにより、配糖体の精製標品を得ることができる。
Hereinafter, the present invention will be described in detail.
A method for producing a glycoside obtained by the present invention is as follows. 0.1-30%, preferably 0.5-5% of a compound having a phenolic hydroxyl group such as phenol, 1,3-dihydroxybenzene, 3-hydroxybenzyl alcohol, (+) catechin or kojic acid, malto-oligosaccharide, amylose, amylopectin or Γ-CGTase is added to a solution containing 0.1 to 30%, preferably 0.5 to 20%, of a sugar donor such as various starches, and 20 to 60 ° C, preferably 30 to 50 ° C, preferably 1 to 48 hours, preferably Let react for 10-24 hours to obtain a reaction solution. The pH of the reaction is preferably the optimum pH of the enzyme to be used, but can be determined in consideration of the solubility of the reaction product. For example, it is 3-11, preferably 5-9. A purified preparation of glycoside can be obtained by partitioning the reaction solution with various solvents and purifying by various chromatography.

また、本発明により得られる糖転移生成物の製造法は次の通りである。D−マンノースやL−ラムノース等の糖類0.1〜30%、好ましくは1〜10%と、マルトオリゴ糖、アミロース、アミロペクチン又は各種スターチ等の糖供与体0.1〜30%、好ましくは1〜10%とを含む溶液に、γ-CGTaseを添加し、20〜60℃、好ましくは30〜50℃で1〜48時間、好ましくは10〜24時間作用させ、反応液を得る。当該反応のpHは使用する酵素の至適pHが良いが反応物の溶解性などを考慮して定めることができる。例えば、3〜11で、好ましくは5〜9である。各種溶媒による分配及び各種クロマトグラフィーによる精製により、この反応液から糖転移生成物の精製標品を得ることができる。   Moreover, the manufacturing method of the glycosyl transfer product obtained by this invention is as follows. Saccharides such as D-mannose and L-rhamnose 0.1 to 30%, preferably 1 to 10%, and sugar donors such as maltooligosaccharide, amylose, amylopectin or various starches, and 0.1 to 30%, preferably 1 to 10% Γ-CGTase is added to the contained solution and allowed to act at 20 to 60 ° C., preferably 30 to 50 ° C. for 1 to 48 hours, preferably 10 to 24 hours, to obtain a reaction solution. The pH of the reaction is good for the enzyme used, but can be determined in consideration of the solubility of the reaction product. For example, it is 3 to 11, preferably 5 to 9. A purified preparation of a glycosyl transfer product can be obtained from this reaction solution by partitioning with various solvents and purification by various chromatography.

本発明に用いられるフェノール性水酸基を有する化合物とは、例えばPhenol、Benzyl alcohol、1,2−Dihydroxybenzene、1,3−Dihydroxybenzene、1,4−Dihydroxybenzene、1,2,3−Trihydroxybenzene、1,3,5−Trihydroxybenzene、3−Hydroxybenzoic acid、4−Hydroxybenzoic acid、2−Hydroxybenzyl alcohol、3−Hydroxybenzyl alcohol、4−Hydroxybenzyl alcohol、Caffeic acid、Gallic acid、(+)-Catechin、(-)-Epigallocatechin gallate、Kojic acid、Ascorbic acid、p-Nitrophenol等が挙げられるが、他起源(例えばバチルス・マセランスやバチルス・ステアロサーモフィラス)由来のCGTaseに比べて配糖体の生成が良好なものとしては、例えばPhenol、1,3−Dihydroxybenzene、3−Hydroxybenzyl alcohol、(+)Catechin、Kojic acid等である。   Examples of the compound having a phenolic hydroxyl group used in the present invention include Phenol, Benzyl alcohol, 1,2-Dihydroxybenzene, 1,3-Dihydroxybenzene, 1,4-Dihydroxybenzene, 1,2,3-Trihydroxybenzene, 1,3, 5-Trihydroxybenzene, 3-Hydroxybenzoic acid, 4-Hydroxybenzoic acid, 2-Hydroxybenzyl alcohol, 3-Hydroxybenzyl alcohol, 4-Hydroxybenzyl alcohol, Caffeic acid, Gallic acid, (+)-Catechin, (-)-Epigallocatechin gallate, Kojic acid Ascorbic acid, p-Nitrophenol, and the like. Examples of those that produce a glycoside better than CGTase derived from other sources (for example, Bacillus macerans and Bacillus stearothermophilus) include Phenol, 1,3-Dihydroxybenzene, 3-Hydroxybenzyl alcohol, (+) Catechin, Kojic acid and the like.

また、単糖類としてはD-glucose、D-galactose、D-mannose、D-fructose、D-glucosamine、D-arabinose、L-arabinose、D-xylose、D-ribose、D-fucose、L-fucose、L-rhamnose等が挙げられるが、他起源(例えばバチルス・マセランスやバチルス・ステアロサーモフィラス)由来のCGTaseに比べて糖転移生成物の生成が良好なものとしては、例えばD-mannose、L-rhamnoseが挙げられる。   Monosaccharides include D-glucose, D-galactose, D-mannose, D-fructose, D-glucosamine, D-arabinose, L-arabinose, D-xylose, D-ribose, D-fucose, L-fucose, L-rhamnose and the like can be mentioned, but examples of those with better transglycosylation products than CGTases derived from other sources (for example, Bacillus macerans and Bacillus stearothermophilus) include D-mannose and L -rhamnose.

本発明に使用するγ-CGTaseとは、澱粉に作用してサイクロデキストリンを生成する作用を有するサイクロデキストリン・グルカノトランスフェラーゼに分類される酵素であり、澱粉溶液に作用させたときに、α、β、γ型の各サイクロデキストリンのうち、主にγ型を生産する酵素をいう。例えばバチルス・エスピー(Bacillus sp.)AL6のCGTase(特開昭61-274680)、バチルス・エスピー(Bacillus sp.)No.313 のCGTase(特開昭62-25976)及びバチルス・フィルムス(Bacillus firmus)290-3のCGTase〔New trend in cyclodextrins and derivatives 25頁(1991年)、サンテ(Sante)社(フランス、パリ)出版〕やブレビバクテリウム(Brevibacterium)属の生産するCGTase(特開平6-113842)、バチルス・メガテリウム(Bacillus megaterium)の生産するCGTase(特開平6-113843)、より具体的にはブレビバクテリウム・エスピー(Brevibacterium sp.)No.9605(FERM BP-4537)由来のγ-CGTase等が挙げられる。より好ましくは、その作用pHの広さからブレビバクテリウム・エスピーNo.9605由来のγ-CGTaseが使用できる。   Γ-CGTase used in the present invention is an enzyme classified as cyclodextrin / glucanotransferase having an action of acting on starch to produce cyclodextrin, and α, β when acting on a starch solution. Among the γ-type cyclodextrins, it refers to an enzyme that mainly produces the γ-type. For example, Bacillus sp. AL6 CGTase (JP 61-274680), Bacillus sp. No. 313 CGTase (JP 62-25976) and Bacillus firmus 290-3 CGTase [New trend in cyclodextrins and derivatives 25 (1991), published by Sante (Paris, France)] and CGTase produced by Brevibacterium (Japanese Patent Laid-Open No. 6-11842) ), CGTase produced by Bacillus megaterium (JP-A-6-113843), more specifically, γ-CGTase derived from Brevibacterium sp. No. 9605 (FERM BP-4537) Etc. More preferably, γ-CGTase derived from Brevibacterium sp. No. 9605 can be used because of its wide working pH.

本発明に使用するγ-CGTaseの添加量は、受容体(フェノール性水酸基を有する化合物又は糖類)と糖供与体の合計重量1グラム当たり10単位以上、望ましくは50〜200単位である。また、本発明において、γ-CGTaseの活性は以下のようにして求めた。   The amount of γ-CGTase used in the present invention is 10 units or more, preferably 50 to 200 units, per gram of the total weight of the acceptor (compound or saccharide having a phenolic hydroxyl group) and the sugar donor. In the present invention, the activity of γ-CGTase was determined as follows.

活性測定法:基質〔1.5%可溶性澱粉、0.1M アトキンス・パンチン(Atkins & Pantin)緩衝液(pH10.0)〕0.5mlに酵素液0.05mlを添加し、40℃にて30分間反応した。その後、0.1N塩酸5mlを加え反応を停止し、0.5mlを抜き取り、ヨウ素液5mlを加え。660nmでの吸光度の減少を測定した。1単位は、本条件下、1分間に660nmの吸光度を1%減少させる酵素量とした。   Activity measurement method: 0.05 ml of enzyme solution was added to 0.5 ml of a substrate [1.5% soluble starch, 0.1 M Atkins & Pantin buffer (pH 10.0)], and reacted at 40 ° C. for 30 minutes. Thereafter, 5 ml of 0.1N hydrochloric acid was added to stop the reaction, 0.5 ml was taken out, and 5 ml of iodine solution was added. The decrease in absorbance at 660 nm was measured. One unit was defined as the amount of enzyme that decreased the absorbance at 660 nm by 1% per minute under the present conditions.

以下に試験例及び実施例にて本発明を具体的に説明するが、本発明はこれらによって何等限定されるものではない。   The present invention will be specifically described below with reference to test examples and examples, but the present invention is not limited to these examples.

配糖体の製造
2.5(w/v)%溶性澱粉(片山化学製)、表1記載の各種受容体(フェノール性水酸基を有する化合物)を2.5(w/v)%、各種CGTaseを1.2単位含む反応液200μl(各pHの緩衝液濃度50mM)を調製し、40℃で20時間反応した。尚、pH5.5は5mM CaClを含む酢酸緩衝液、pH7.0及び9.0は5mM CaClを含むホウ酸緩衝液を使用した。但し、(+)-Catechin、(-)-Epigallocatechin gallate、p-Nitrophenolは濃度として、0.5(w/v)%として反応に供した。また、CGTaseとしてはバチルス・マセランス由来(商品名:コンチザイム、天野製薬社製)(表1に於いて、酵素1と記載)、バチルス・ステアロサーモフィラス由来(林原生化学工業社製)(表1に於いて、酵素2と記載)及びブレビバクテリウム・エスピー(Brevibacterium sp.)No.9605(FERM BP-4537)由来(天野製薬社製)(表1に於いて、酵素3と記載)を使用した。
Production of glycosides
Reaction solution containing 2.5 (w / v)% soluble starch (manufactured by Katayama Chemical), various receptors listed in Table 1 (compounds having a phenolic hydroxyl group) 2.5 (w / v)%, and 1.2 units of various CGTases (each pH buffer concentration 50 mM) was prepared and reacted at 40 ° C. for 20 hours. The pH 5.5 used an acetate buffer containing 5 mM CaCl 2 , and the pH 7.0 and 9.0 used a borate buffer containing 5 mM CaCl 2 . However, (+)-Catechin, (-)-Epigallocatechin gallate, and p-Nitrophenol were subjected to the reaction at concentrations of 0.5 (w / v)%. Also, CGTase is derived from Bacillus macerans (trade name: Contiszyme, Amano Pharmaceutical Co., Ltd.) (described as enzyme 1 in Table 1), derived from Bacillus stearothermophilus (produced by Hayashibara Seikagaku Corporation) ( In Table 1, described as enzyme 2) and from Brevibacterium sp. No. 9605 (FERM BP-4537) (manufactured by Amano Pharmaceutical Co., Ltd.) (described as enzyme 3 in Table 1) It was used.

各種受容体への転移率はHPLCによる分析にて全ピーク面積に対する転移生成物のピーク面積の比として表した。なお、HPLCの分析条件としては、カラム:YMC ODS-AQ303(YMC社製)、カラム温度:30℃、流速:1.0ml/分で行い、溶媒としては以下を使用した。   The transfer rate to various receptors was expressed as the ratio of the peak area of the transfer product to the total peak area by HPLC analysis. The HPLC analysis conditions were as follows: column: YMC ODS-AQ303 (manufactured by YMC), column temperature: 30 ° C., flow rate: 1.0 ml / min, and the following was used as the solvent.

(A) : 20(v/v)%メタノール(リン酸でpH2.5に調製)
(B) : 30(v/v)%メタノール(リン酸でpH2.5に調製)
(C) : 40(v/v)%メタノール(リン酸でpH2.5に調製)
(D) : 7.5(v/v)%メタノール(リン酸でpH2.5に調製)
(E) : 50mM KHPO(リン酸でpH2.5に調製)
(F) : 50(v/v)%メタノール(リン酸でpH2.5に調製)
(A): 20 (v / v)% methanol (prepared to pH 2.5 with phosphoric acid)
(B): 30 (v / v)% methanol (prepared to pH 2.5 with phosphoric acid)
(C): 40 (v / v)% methanol (prepared to pH 2.5 with phosphoric acid)
(D): 7.5 (v / v)% methanol (prepared to pH 2.5 with phosphoric acid)
(E): 50 mM KH 2 PO 4 (adjusted to pH 2.5 with phosphoric acid)
(F): 50 (v / v)% methanol (prepared to pH 2.5 with phosphoric acid)

また、表1において、各種受容体は以下の略名で示した。表中で「−−」は受容体が分解していたため配糖体の生成が確認できなかったことを示す。   In Table 1, various receptors are indicated by the following abbreviations. In the table, “-” indicates that the production of glycoside could not be confirmed because the receptor was decomposed.

1,2-DHB : 1,2-Dihydroxybenzene(Catechol)
1,3-DHB : 1,3-Dihydroxybenzene(Resorcin)
1,4-DHB : 1,4-Dihydroxybenzene(Hydroquinone)
1,2,3-THB : 1,2,3-Trihydroxybenzene(Pyrogallol)
1,3,5-THB : 1,3,5-Trihydroxybenzene(Phloroglucinol)
3-HBAD : 3-Hydroxybenzoic acid
4-HBAD : 4-Hydroxybenzoic acid
2-HBAL : 2-Hydroxybenzyl alcohol
3-HBAL : 3-Hydroxybenzyl alcohol
4-HBAL : 4-Hydroxybenzyl alcohol
(-)-EGCg : (-)-Epigallocatechin gallate
1,2-DHB: 1,2-Dihydroxybenzene (Catechol)
1,3-DHB: 1,3-Dihydroxybenzene (Resorcin)
1,4-DHB: 1,4-Dihydroxybenzene (Hydroquinone)
1,2,3-THB: 1,2,3-Trihydroxybenzene (Pyrogallol)
1,3,5-THB: 1,3,5-Trihydroxybenzene (Phloroglucinol)
3-HBAD: 3-Hydroxybenzoic acid
4-HBAD: 4-Hydroxybenzoic acid
2-HBAL: 2-Hydroxybenzyl alcohol
3-HBAL: 3-Hydroxybenzyl alcohol
4-HBAL: 4-Hydroxybenzyl alcohol
(-)-EGCg: (-)-Epigallocatechin gallate

Figure 2005312464
Figure 2005312464

表1からも明らかなように、ブレビバクテリウム属由来の酵素(酵素3)を使用した場合、バチルス・ステアロサーモフィラス由来のCGTaseと同様に広い受容体特異性を有し、特にフェノール、1,3-ジヒドロキシベンゼン、3−ヒドロキシベンジル アルコール、(+)−カテキン及びコウジ酸については配糖体を多く合成する。   As is apparent from Table 1, when an enzyme derived from the genus Brevibacterium (enzyme 3) is used, it has a wide receptor specificity like CGTase derived from Bacillus stearothermophilus, especially phenol, For 1,3-dihydroxybenzene, 3-hydroxybenzyl alcohol, (+)-catechin and kojic acid, many glycosides are synthesized.

また、ブレビバクテリウム属由来の酵素は、中性(pH 7.0)やアルカリ性(pH 9.0)でも配糖体の合成能力があり、受容体の溶解性などの点で中性或いはアルカリ側での反応を必要とする場合に特に有用である。   In addition, enzymes derived from the genus Brevibacterium are capable of synthesizing glycosides even when neutral (pH 7.0) or alkaline (pH 9.0), and neutral or alkaline reactions in terms of receptor solubility. It is particularly useful when it is necessary.

反応pHによる比較
実施例1と同様にして酵素1、酵素2及び酵素3について1,3-ジヒドロキシベンゼン、1,3,5-トリヒドロキシベンゼン、(+)-カテキン及びコウジ酸を受容体として、pH5.5及びpH7.0の場合を比較した。その結果を表2に示す。表中において比率aは各々の酵素に於けるpH5.5とpH7.0の生成比率を示し、比率bは酵素1の各pHにおける配糖体生成量を1としたときのpH5.5及びpH7.0での各々の酵素用いた場合の生成比率を示す。
Comparative Example According to Reaction pH In the same manner as in Example 1, 1,3-dihydroxybenzene, 1,3,5-trihydroxybenzene, (+)-catechin and kojic acid were used as receptors for enzyme 1, enzyme 2 and enzyme 3. The cases of pH 5.5 and pH 7.0 were compared. The results are shown in Table 2. In the table, the ratio a represents the production ratio of pH 5.5 and pH 7.0 in each enzyme, and the ratio b represents pH 5.5 and pH 7 when the amount of glycoside produced at each pH of enzyme 1 is 1. The production ratio when using each enzyme at 0.0 is shown.

Figure 2005312464
Figure 2005312464

表2からも明らかなように、ブレビバクテリウム由来の酵素(酵素3)はpH7.0でも良好な配糖体生成率を示し、特に(+)-カテキンの場合には、ほとんどpHの影響もなく高い生成率を示した。   As is clear from Table 2, the enzyme derived from Brevibacterium (enzyme 3) shows a good glycoside formation rate even at pH 7.0, and in particular in the case of (+)-catechin, there is almost no influence of pH. It showed a high production rate.

糖転移体の製造
5(w/v)%溶性澱粉(片山化学製)、各種単糖類(受容体)を5(w/v)%、各種CGTaseを0.6単位含む反応液200μl(各pHの緩衝液濃度30mM)を調製し、40℃で20時間反応した。尚、pH5.5は5mM CaClを含む酢酸緩衝液、pH9.0は5mM CaClを含むホウ酸緩衝液を使用した。また、CGTaseとしてはバチルス・マセランス由来、バチルス・ステアロサーモフィラス由来及びブレビバクテリウム・エスピー(Brevibacterium sp.)No.9605(FERM BP-4537)由来を使用した。反応後、反応液3μlを使用してTLCで糖転移生成物を分析した。その結果を図1に示す。図中の記号は以下の場合を示す。
Manufacture of glycosyltransferases 5 (w / v)% soluble starch (manufactured by Katayama Chemical), 200 μl of reaction solution containing 5 units (w / v)% of various monosaccharides (receptors) and 0.6 units of various CGTases (buffer at each pH) A liquid concentration of 30 mM) was prepared and reacted at 40 ° C. for 20 hours. The pH 5.5 used an acetate buffer containing 5 mM CaCl 2 , and the pH 9.0 used a borate buffer containing 5 mM CaCl 2 . Further, as CGTase, those derived from Bacillus macerans, Bacillus stearothermophilus and Brevibacterium sp. No. 9605 (FERM BP-4537) were used. After the reaction, the transglycosylation product was analyzed by TLC using 3 μl of the reaction solution. The result is shown in FIG. The symbols in the figure indicate the following cases.

R :オリゴ糖混合液
(グルコース、マルトース、マルトトリオース、マルトテトラオース)
Bl :ブランク(酵素液の代わりに水を用いて同様に反応した)
M :バチルス・マセランス由来のCGTaseを使用した場合
S :バチルス・ステアロサーモフィラス由来のCGTaseを使用した場合
B :ブレビバクテリウム・エスピーNo.9605由来のγ-CGTaseを使用した場合
R: oligosaccharide mixture
(Glucose, maltose, maltotriose, maltotetraose)
Bl: Blank (reacted in the same manner using water instead of enzyme solution)
M: When using CGTase derived from Bacillus macerans S: When using CGTase derived from Bacillus stearothermophilus B: When using γ-CGTase derived from Brevibacterium sp. No. 9605

(1) :受容体を含まない場合
(2) :受容体としてD−グルコースを使用
(3) :受容体としてD−ガラクトースを使用
(4) :受容体としてD−マンノースを使用
(5) :受容体としてD−フルクトースを使用
(6) :受容体としてD−グルコサミンを使用
(7) :受容体としてD−アラビノースを使用
(8) :受容体としてL−アラビノースを使用
(9) :受容体としてD−キシロースを使用
(10) :受容体としてD−リボースを使用
(11) :受容体としてD−フコースを使用
(12) :受容体としてL−フコースを使用
(13) :受容体としてL−ラムノースを使用
(1) When no receptor is included
(2): D-glucose used as a receptor
(3): D-galactose is used as a receptor
(4): Uses D-mannose as a receptor
(5): Use D-fructose as a receptor
(6): Uses D-glucosamine as a receptor
(7): D-arabinose is used as a receptor
(8): L-arabinose is used as a receptor
(9): D-xylose is used as a receptor
(10): Use D-ribose as the acceptor
(11): Use D-fucose as a receptor
(12): L-fucose is used as a receptor
(13): L-rhamnose is used as a receptor

ブレビバクテリウム・エスピーNo.9605由来のγ-CGTaseを使用した場合、バチルス・ステアロサーモフィラス由来のCGTaseを使用した場合と同様に、その受容体特異性は広く、特にD−マンノース、L−ラムノースを受容体とした場合には転移生成物を多く合成した。   When γ-CGTase derived from Brevibacterium sp. No. 9605 is used, the receptor specificity is wide as in the case of using CGTase derived from Bacillus stearothermophilus, especially D-mannose, L -When rhamnose was used as a receptor, many transfer products were synthesized.

実施例3のTCL結果を示す図である。It is a figure which shows the TCL result of Example 3.

Claims (5)

フェノール性水酸基を有する化合物と糖供与体にγ−サイクロデキストリン・グルカノトランスフェラーゼを作用させることを特徴とする配糖体の製造法。   A method for producing a glycoside, comprising reacting a compound having a phenolic hydroxyl group and a sugar donor with γ-cyclodextrin / glucanotransferase. 糖類と糖供与体にγ−サイクロデキストリン・グルカノトランスフェラーゼを作用させることを特徴とする糖転移生成物の製造法。   A method for producing a glycosyl transfer product, which comprises reacting a saccharide and a sugar donor with γ-cyclodextrin / glucanotransferase. 中性又はアルカリ性の条件で作用させることを特徴とする請求項1或いは請求項2記載の製造法。   The production method according to claim 1 or 2, wherein the method is operated under neutral or alkaline conditions. γ−サイクロデキストリン・グルカノトランスフェラーゼがブレビバクテリウム属由来の酵素である請求項1又は請求項2記載の製造法。   The production method according to claim 1 or 2, wherein the γ-cyclodextrin glucanotransferase is an enzyme derived from the genus Brevibacterium. ブレビバクテリウム属に属する微生物がブレビバクテリウム・エスピーNo.9605(FERM BP-4537)である請求項4記載の製造法。
The process according to claim 4, wherein the microorganism belonging to the genus Brevibacterium is Brevibacterium sp. No. 9605 (FERM BP-4537).
JP2005213937A 2005-07-25 2005-07-25 Method for producing glycoside and transglucosylation product Pending JP2005312464A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2005213937A JP2005312464A (en) 2005-07-25 2005-07-25 Method for producing glycoside and transglucosylation product

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2005213937A JP2005312464A (en) 2005-07-25 2005-07-25 Method for producing glycoside and transglucosylation product

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP18616995A Division JP3718543B2 (en) 1995-06-28 1995-06-28 Process for producing glycosides and glycosyl transfer products

Publications (1)

Publication Number Publication Date
JP2005312464A true JP2005312464A (en) 2005-11-10

Family

ID=35440557

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2005213937A Pending JP2005312464A (en) 2005-07-25 2005-07-25 Method for producing glycoside and transglucosylation product

Country Status (1)

Country Link
JP (1) JP2005312464A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007215506A (en) * 2006-02-17 2007-08-30 Ucc Ueshima Coffee Co Ltd Method for producing cinnamic acid glycoside
KR101048354B1 (en) * 2009-01-07 2011-07-14 전라남도 Method for preparing caffeic acid glycosides
CN109497229A (en) * 2018-12-24 2019-03-22 桂林莱茵生物科技股份有限公司 A method of improving Sweet tea glucoside extract mouthfeel

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007215506A (en) * 2006-02-17 2007-08-30 Ucc Ueshima Coffee Co Ltd Method for producing cinnamic acid glycoside
KR101048354B1 (en) * 2009-01-07 2011-07-14 전라남도 Method for preparing caffeic acid glycosides
CN109497229A (en) * 2018-12-24 2019-03-22 桂林莱茵生物科技股份有限公司 A method of improving Sweet tea glucoside extract mouthfeel

Similar Documents

Publication Publication Date Title
Aga et al. Synthesis of 2-O-α-D-glucopyranosyl L-ascorbic acid by cyclomaltodextrin glucanotransferase from Bacillus stearothermophilus
Kandra α-Amylases of medical and industrial importance
Monsan et al. Enzymatic synthesis of oligosaccharides
EP0841398B1 (en) Kojibiose Phosphorylase, its preparation and use
Mathew et al. Regioselective glycosylation of hydroquinone to α-arbutin by cyclodextrin glucanotransferase from Thermoanaerobacter sp.
Karthaus et al. Cellulase-catalysed glycosylation reactions: simple route towards a highly selective synthesis of oligosaccharides
JP2005312464A (en) Method for producing glycoside and transglucosylation product
US7223570B2 (en) Branched cyclic tetrasaccharide, process for producing the same, and use
ES2870566T3 (en) Synthesis of long chain alkylglycosides
JP3718543B2 (en) Process for producing glycosides and glycosyl transfer products
JPH01157996A (en) Maltooligo saccharide derivative and reagent for measuring amylase activity
Trincone et al. Glycosynthase-catalysed syntheses at pH below neutrality
WO2021193498A1 (en) Collagenase activity inhibitor
Shibuya et al. Enzymatic synthesis of a novel trisaccharide, glucosyl lactoside
渋谷孝 et al. Production of turanose by cyclomaltodextrin glucanotransferase from Bacillus stearothermophilus
Nilsson et al. Production of glucosamine containing disaccharides of the Lewis-A and-x types employing glycosidases
EP0263027A1 (en) Glycosidation catalyst and process for preparing glycoside derivatives
Yan et al. Synthesis of cello-oligosaccharides from cellobiose with β-glucosidase II from Aspergillus niger
Milosavić et al. A simple and efficient one-step, regioselective, enzymatic glucosylation of arbutin by α-glucosidase
JP3851625B2 (en) Whitening agent containing phenolic compound rutinose glycoside as an active ingredient
JP3787002B2 (en) Method for producing a rutinose glycoside of a phenol compound
Shibuya et al. Transglycosylation of glycosyl residues to cyclic tetrasaccharide by Bacillus stearothermophilus cyclomaltodextrin glucanotransferase using cyclomaltodextrin as the glycosyl donor
JP3796809B2 (en) Phenol-type glycoside and method for producing the same
EP1861503A2 (en) Method for synthesizing oligosaccharides and glycosylation
MORI et al. Acceptor specificity of cyclodextrin glucanotransferase from Brevibacterium sp. No. 9605 to monosaccharides and phenolic compounds

Legal Events

Date Code Title Description
A621 Written request for application examination

Effective date: 20050729

Free format text: JAPANESE INTERMEDIATE CODE: A621

A131 Notification of reasons for refusal

Effective date: 20051206

Free format text: JAPANESE INTERMEDIATE CODE: A131

A521 Written amendment

Effective date: 20060203

Free format text: JAPANESE INTERMEDIATE CODE: A523

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20060314